Huang Michael F., Senior VP of Clinical Development at Soleno Therapeutics ($SLNO), sold shares on the open market nine times over the past year, totaling about 1.01 million dollars. His most recent sale occurred on March 27, 2025. These sales rank 4,883rd among 11,678 insiders in our database by value sold, below the average of 8.6 million dollars per insider and 6.4 transactions. Huang made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 488 | $31.72 | 39,823.0000 | 54,921,916 | 1.21% | 0.00% |
| March 27, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 1838 | $31.04 | 40,311.0000 | 54,921,916 | 4.36% | 0.00% |
| March 27, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 4256 | $30.04 | 42,149.0000 | 54,921,916 | 9.17% | 0.01% |
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | A | Common Stock | 10400 | $0.00 | 46,405.0000 | 54,921,916 | 28.88% | 0.02% |
| Jan. 21, 2026 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | A | Employee stock option (right to buy) | 11900 | $0.00 | 11,900.0000 | 54,921,916 | 9999.99% | 0.02% |
| Dec. 15, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | F | Common Stock | 812 | $49.95 | 36,005.0000 | 54,921,916 | 2.21% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 125 | $71.74 | 36,836.0000 | 40,175,926 | 0.34% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 19 | $72.64 | 36,817.0000 | 40,175,926 | 0.05% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | M | Common Stock | 10000 | $21.93 | 46,817.0000 | 40,175,926 | 27.16% | 0.02% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 10000 | $70.03 | 36,817.0000 | 40,175,926 | 21.36% | 0.02% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 371 | $65.97 | 41,029.0000 | 40,175,926 | 0.90% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | M | Employee stock option (right to buy) | 10000 | $0.00 | 110,000.0000 | 40,175,926 | 8.33% | 0.02% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 604 | $66.79 | 40,425.0000 | 40,175,926 | 1.47% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 1098 | $67.70 | 39,327.0000 | 40,175,926 | 2.72% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 1444 | $68.79 | 37,883.0000 | 40,175,926 | 3.67% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 836 | $69.84 | 37,047.0000 | 40,175,926 | 2.21% | 0.00% |
| March 27, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | S | Common Stock | 86 | $70.73 | 36,961.0000 | 40,175,926 | 0.23% | 0.00% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | A | Employee stock option (right to buy) | 13800 | $0.00 | 13,800.0000 | 40,175,926 | 9999.99% | 0.03% |
| Jan. 21, 2025 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | A | Common Stock | 6400 | $0.00 | 41,400.0000 | 40,175,926 | 18.29% | 0.02% |
| July 17, 2024 | SOLENO THERAPEUTICS INC | $SLNO | Huang Michael F. | Sr. VP of Clinical Development | A | Common Stock | 35000 | $0.00 | 35,000.0000 | 16,492,132 | 9999.99% | 0.21% |